Ascentage Pharma Group International (AAPG) Retained Earnings (2023 - 2025)

Ascentage Pharma Group International's Retained Earnings history runs 3 years deep, the most recent figure standing at -$988.8 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 23.09% year-over-year to -$988.8 million; the TTM figure through Dec 2025 stood at -$988.8 million (down 23.09% YoY), while the FY2025 annual figure was -$1.0 billion, down 26.86% from the prior year.
• Retained Earnings for Q4 2025 stood at -$988.8 million, down from -$803.4 million in the prior quarter.
• The five-year high for Retained Earnings was -$745.1 million in Q4 2023, with the low at -$988.8 million in Q4 2025.
• The 3-year median for Retained Earnings is -$803.4 million (2024), against an average of -$845.8 million.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings declined 7.81% in 2024, then declined 23.09% in 2025.
• Ascentage Pharma Group International's Retained Earnings stood at -$745.1 million in 2023, then declined by 7.81% to -$803.4 million in 2024, then slipped by 23.09% to -$988.8 million in 2025.
• Business Quant data shows AAPG's Retained Earnings at -$988.8 million in Q4 2025, -$803.4 million in Q4 2024, and -$745.1 million in Q4 2023.